BRXL_ECOHS
ID BRXL_ECOHS Reviewed; 694 AA.
AC P0DUG1; A0A7M3S2P6;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 02-JUN-2021, sequence version 1.
DT 03-AUG-2022, entry version 5.
DE RecName: Full=Lon-like protease BrxL {ECO:0000303|PubMed:30418590};
DE AltName: Full=BREX protein BrxL {ECO:0000303|PubMed:30418590};
GN Name=brxL {ECO:0000303|PubMed:30418590}; OrderedLocusNames=EcHS_A0341;
OS Escherichia coli O9:H4 (strain HS).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=331112;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=HS;
RX PubMed=18676672; DOI=10.1128/jb.00619-08;
RA Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA Henderson I.R., Sperandio V., Ravel J.;
RT "The pangenome structure of Escherichia coli: comparative genomic analysis
RT of E. coli commensal and pathogenic isolates.";
RL J. Bacteriol. 190:6881-6893(2008).
RN [2]
RP FUNCTION IN ANTIVIRAL DEFENSE, INDUCTION, AND DISRUPTION PHENOTYPE.
RC STRAIN=HS;
RX PubMed=30418590; DOI=10.1093/nar/gky1125;
RA Gordeeva J., Morozova N., Sierro N., Isaev A., Sinkunas T., Tsvetkova K.,
RA Matlashov M., Truncaite L., Morgan R.D., Ivanov N.V., Siksnys V., Zeng L.,
RA Severinov K.;
RT "BREX system of Escherichia coli distinguishes self from non-self by
RT methylation of a specific DNA site.";
RL Nucleic Acids Res. 47:253-265(2019).
CC -!- FUNCTION: BREX systems (bacteriophage exclusion) provide immunity
CC against bacteriophage. Part of a type 1 BREX system which protects
CC against dsDNA phage. This system allows phage adsorption but prevents
CC phage DNA replication, without degradation of the phage DNA.
CC Methylation of bacterial DNA by PglX guides self/non-self
CC discrimination. When the brxA-brxB-brxC-pglX-pglZ-brxL genes are
CC transformed into a susceptible E.coli strain (BW25113) they confer very
CC high resistance to infection by bacteriophage VR7 and VpaE1, about 100-
CC fold protection against lambda, T5 and T7 and no protection against RNA
CC phage Qbeta, ssDNA phage M13 or dSDNA phage T4 and VR5. Glycosylated
CC phage DNA is not susceptible to BREX. The BREX system does not confer
CC resistance to lysogenic lambda phage, i.e. prophage that are integrated
CC into the chromosomal DNA and then induced to form phage. Expression of
CC this protein alone is toxic. {ECO:0000269|PubMed:30418590}.
CC -!- INDUCTION: Transcribed at similar levels in lag and exponential phase,
CC rises in stationary phase. {ECO:0000269|PubMed:30418590}.
CC -!- DISRUPTION PHENOTYPE: Methylation of 5'-GGTAAG-3' in chromosomal DNA,
CC however BREX no longer confers phage resistance.
CC {ECO:0000269|PubMed:30418590}.
CC -!- SIMILARITY: Belongs to the BrxL family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000802; ABV04729.1; -; Genomic_DNA.
DR RefSeq; WP_001193073.1; NC_009800.1.
DR AlphaFoldDB; P0DUG1; -.
DR SMR; P0DUG1; -.
DR KEGG; ecx:EcHS_A0341; -.
DR OMA; FRNTHFS; -.
DR Proteomes; UP000001123; Chromosome.
DR GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR GO; GO:0004176; F:ATP-dependent peptidase activity; IEA:InterPro.
DR GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR GO; GO:0030163; P:protein catabolic process; IEA:InterPro.
DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR Gene3D; 3.30.230.10; -; 1.
DR InterPro; IPR013473; BrxL.
DR InterPro; IPR014061; BrxL-like.
DR InterPro; IPR008269; Lon_proteolytic.
DR InterPro; IPR027065; Lon_Prtase.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR PANTHER; PTHR10046; PTHR10046; 1.
DR Pfam; PF13337; Lon_2; 1.
DR Pfam; PF05362; Lon_C; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR SUPFAM; SSF54211; SSF54211; 1.
DR TIGRFAMs; TIGR02653; Lon_rel_chp; 1.
DR TIGRFAMs; TIGR02688; TIGR02688; 1.
PE 1: Evidence at protein level;
KW Antiviral defense; Hydrolase; Protease.
FT CHAIN 1..694
FT /note="Lon-like protease BrxL"
FT /id="PRO_0000452160"
SQ SEQUENCE 694 AA; 77373 MW; 4AB686BBE0A0C114 CRC64;
MQTHHDLPVS GVSAGEIASE GYDLDALLNQ HFAGRVVRKD LTKQLKEGAN VPVYVLEYLL
GMYCASDDDD VVEQGLQNVK RILADNYVRP DEAEKVKSLI RERGSYKIID KVSVKLNQKK
DVYEAQLSNL GIKDALVPSQ MVKDNEKLLT GGIWCMITVN YFFEEGQKTS PFSLMTLKPI
QMPNMDMEEV FDARKHFNRD QWIDVLLRSV GMEPANIEQR TKWHLITRMI PFVENNYNVC
ELGPRGTGKS HVYKECSPNS LLVSGGQTTV ANLFYNMASR QIGLVGMWDV VAFDEVAGIT
FKDKDGVQIM KDYMASGSFS RGRDSIEGKA SMVFVGNINQ SVETLVKTSH LLAPFPAAMI
DTAFFDRFHA YIPGWEIPKM RPEFFTNRYG LITDYLAEYM REMRKRSFSD AIDKFFKLGN
NLNQRDVIAV RRTVSGLLKL MHPDGAYSKE DVRVCLTYAM EVRRRVKEQL KKLGGLEFFD
VNFSYIDNET LEEFFVSVPE QGGSELIPAG MPKPGVVHLV TQAESGMTGL YRFETQMTAG
NGKHSVSGLG SNTSAKEAIR VGFDYFKGNL NRVSAAAKFS DHEYHLHVVE LHNTGPSTAT
SLAALIALCS ILLAKPVQEQ MVVLGSMTLG GVINPVQDLA ASLQLAFDSG AKRVLLPMSS
AMDIPTVPAE LFTKFQVSFY SDPVDAVYKA LGVN